Endocrinology Editors and Editorial Board

Editor-in-Chief

Zane B. Andrews, PhD
Monash University
Clayton, Australia

Dr. Andrews is a National Health and Medical Research Council of Australia research fellow and an associate professor at the Monash Biomedicine Discovery Institute and Department of Physiology at Monash University in Melbourne, Australia. His research interests include neuroendocrinology, obesity and metabolism, and diabetes. His current research focuses on understanding neuroendocrine control of metabolism, mood, and motivation, with a particular attention to the neuroendocrine actions of ghrelin and ghrelin-target cells in the brain.

Deputy Editor

Gail S. Prins, PhD
University of Illinois at Chicago
Chicago, Illinois, USA

Dr. Prins is the Michael Reese Professor of Urology, Pathology and Physiology at the University of Illinois at Chicago College of Medicine and Professor of Environmental Health Sciences at UIC School of Public Health. She serves as the co-Director of the NIEHS-designated Chicago Center for Health and Environment (CACHET) at UIC and the University of Chicago. Her research focus is hormonal regulation of prostate gland development and carcinogenesis. Research areas of emphasis include estrogen actions in the prostate gland, human prostate stem and progenitor cells, and the influence of early life exposure to endocrine disrupting chemicals and toxins on adult prostate cancer risk.

Associate Editors

Stanley Andrisse, MBA, PhD
Howard University College of Medicine
Washington, DC, USA

Dr. Stanley Andrisse is an assistant professor at Howard University College of Medicine researching type 2 diabetes and insulin resistance. He studies the role of adipose tissue, hepatocytes, and muscle in contributing to the development of insulin resistance in type 2 diabetes. Dr. Andrisse is interested in sex differences in these processes, in particular the effects of the hyperandrogenism seen in polycystic ovary syndrome as well as racial and ethnic disparities. Dr. Andrisse is a visiting faculty at Georgetown University Medical Center and has held positions at Imperial College London and Johns Hopkins Medicine.

Daniel J. Bernard, PhD
McGill University
Montréal, Québec, Canada

Dr. Bernard is a professor of pharmacology and therapeutics, anatomy and cell biology, physiology, and obstetrics and gynecology at McGill University in Montréal, Québec, Canada. He is the director of the McGill Centre for Research in Reproduction and Development and is a member of the Integrated Program in Neuroscience. The Bernard lab investigates the neuroendocrine control of the reproductive and thyroid axes. The lab is particularly interested in mechanisms of TGFβ superfamily and GnRH regulation of gonadotropin synthesis, as well as mechanisms underlying immunoglobulin superfamily member 1 (IGSF1) deficiency syndrome.

Kristy A. Brown, PhD
University of Kansas Medical Center
Kansas City, Kansas, USA

Dr. Brown is an associate professor of Metabolism and Cancer in the Department of Cell Biology and Physiology at the University of Kansas Medical Center and co-Program Leader of Cancer Prevention and Control at the University of Kansas Cancer Center. Her lab’s research aims to characterize mechanisms of tumor formation and progression in relation to obesity and dysregulated metabolism, and to identify novel strategies for intervention. Her expertise includes mechanisms of aromatase regulation in adipose tissue, as well as the role of adipokines, ghrelin, unacylated ghrelin, inflammatory mediators, and steroid hormones in driving changes in breast cancer cells and cells of the breast microenvironment.

Frances E. Carr, PhD
The University of Vermont
Burlington, Vermont, USA

Dr. Carr is a professor in the Department of Pharmacology and an Associate Director of the UVM Cancer Center in the Larner College of Medicine at the University of Vermont. Her research program is focused on understanding the epigenomic and genomic mechanisms of thyroid hormone action to facilitate understanding of the mechanisms by which thyroid hormones and thyroid hormone receptors regulate development and tumorigenesis. Research areas of emphasis include elucidation of key chromatin-modifying proteins that facilitate thyroid hormone receptor beta tumor suppression in thyroid and breast cancers.

Paola Divieti Pajevic, MD, PhD
Boston University
Boston, Massachusetts, USA

Dr. Divieti Pajevic is an associate professor of translational dental medicine at Boston University's Goldman School of Dental Medicine. Her research explores how mechanical forces and hormonal signals impact osteocytes, both in vitro and in vivo. Her lab has created various tools, including cell lines and transgenic mice, to investigate the molecular and cellular mechanisms underlying bone metabolism and the effects of hormones.

Marina Olga Fernandez, PhD
Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas (IByME-CONICET)
Buenos Aires, Argentina

Dr Fernandez is an Associate Researcher of CONICET at the Instituto de Biología y Medicina Experimental in Buenos Aires, Argentina. Her interests involve understanding how environmental stimuli, such as components of the diet and contaminants, affect the endocrine system. She is presently studying the effects of endocrine-disrupting chemicals on the physiology of the hypothalamic-pituitary axis. She is author or co-author of several papers and a book chapter, and serves as a peer reviewer for academic journals. She is also peer reviewer of grants, promotions, and entries to the Scientific Researcher Career Program of CONICET and FONCyT grants in her home country.

Daniel E. Frigo, PhD
University of Texas MD Anderson Cancer Center
Houston, Texas, USA

Dr. Frigo is a professor in the Departments of Cancer Systems Imaging (primary where he also serves as deputy chair) and Genitourinary Medical Oncology (secondary) at the University of Texas MD Anderson Cancer Center. Dr. Frigo’s research is focused on understanding the basic biology of prostate cancer for the purpose of developing new therapies to treat the advanced stages of the disease. His expertise includes steroid hormone signaling and nuclear receptors, endocrine-related cancers, signal transduction, and cancer metabolism.

J. Dinny Graham, PhD
Westmead Institute for Medical Research
Westmead, Australia

Dr. Graham leads the Translational Breast Cancer Genomics Research program and is Deputy Director at the Centre for Cancer Research at the Westmead Institute for Medical Research, Sydney, Australia. She is also a Senior Translational Fellow within the Westmead Breast Cancer Institute, Westmead Hospital, and the Faculty of Medicine and Health, the University of Sydney. Her research interests are in understanding the context-specific molecular actions of ovarian hormones in the normal breast and breast cancer. Her current research is focused on identifying novel molecular features and cellular phenotypes that predict breast cancer progression and recurrence, with a particular focus on in situ and endocrine sensitive breast cancers.

David R. Grattan, PhD
University of Otago
Dunedin, Otago, New Zealand

Dr. Grattan is a professor in the Department of Anatomy at the University of Otago in Dunedin, New Zealand, and is director of the Otago Centre for Neuroendocrinology. He is also a management principal investigator of the Maurice Wilkins Centre for Molecular Biodiscovery, a New Zealand National Centre of Research Excellence. His research interests center around the prolactin and growth hormone family of hormones, particularly the actions of these hormones in the brain and their role in the neuroendocrine adaptation to pregnancy in the maternal brain.

Patrick E. MacDonald, PhD
University of Alberta
Edmonton, Alberta, Canada

Dr. MacDonald is a professor of Pharmacology at the University of Alberta, Director of the Alberta Diabetes Institute IsletCore, and Canada Research Chair in Islet Biology in Edmonton, Canada. His research interests include pancreatic islet biology in health and diabetes, cellular signalling and post-translational protein modifications, the regulation of endocrine cell excitability and secretory granule exocytosis, and human tissue bio-banking.

Wenwen Zeng, PhD
Tsinghua University
Beijing, China

Dr. Zeng is a professor at the Institute for Immunology and the School of Basic Medical Sciences at Tsinghua University in Beijing. Her group studies the peripheral nervous system in brain-body interactions and neuroimmunology, with a particular focus on the sympathetic nervous system and its role in regulating metabolic activities.

Disclosure Information for the Editor-in-Chief, Deputy Editor, and Associate Editors

Editorial Board

Alfonso Abizaid, PhD

Carleton University
Ottawa, Ontario, Canada

Ana Paula Abreu, MD, PhD

Brigham and Women’s Hospital/Harvard Medical School
Boston, Massachusetts, USA

Alison H. Affinati, MD, PhD

University of Michigan
Ann Arbor, Michigan, USA

Greg M. Anderson, PhD

University of Otago
Dunedin, New Zealand

Lisa M. Arendt, DVM, PhD

University of Wisconsin-Madison
Madison, Wisconsin, USA

Decio Armanini, MD

University of Padova
Padua, Italy

Olga Astapova, MD, PhD

University of Rochester Medical Center
Rochester, New York, USA

Jacqueline L. Beaudry, PhD

University of Toronto
Toronto, Canada

Damasia Becu-Villalobos, PhD

IBYME CONICET
Buenos Aires, Argentina

Jerzy Bełtowski, MD, PhD

Medical University of Lublin
Lublin, Poland

Darlene E. Berryman, PhD, RD, LD

Ohio University
Athens, Ohio, USA

Robert D. Blank, MD, PhD

Medical College of Wisconsin
Milwaukee, Wisconsin, USA
and
Garvan Institute of Medical Research
Sydney, Australia

Gerrit J. Bouma, PhD

Western Michigan University Homer Stryker M.D. School of Medicine
Kalamazoo, Michigan, USA

Kellie M. Breen Church, PhD

University of California, San Diego
La Jolla, California, USA

Andrew J. Brooks, PhD

The University of Queensland
Brisbane, Australia

Rosie Brown, PhD

University of Otago
Dunedin, New Zealand

Rebecca E. Campbell, PhD

University of Otago
Dunedin, New Zealand

Rossella Cannarella, MD, PhD

University of Catania
Catania, Italy

Denise P. Carvalho, MD, PhD

Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil

Ana Cheong, PhD

Harvard T.H. Chan School of Public Health
Boston, Massachusetts, USA

Gwen V. Childs, PhD, FAAA

University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA

Carmen Clapp, PhD

National University of Mexico (UNAM)
Queretaro, Mexico

Jose Cordoba-Chacon, PhD

University of Illinois at Chicago
Chicago, Illinois, USA

Amit K. Dash, PhD

Baylor College of Medicine
Houston, Texas, USA

Carlos A. Díaz-Balzac, MD, PhD

University of Rochester Medical Center
Rochester, New York, USA

Jose Donato, Jr., PhD

University of São Paulo
São Paulo, Brazil

Christine Doucette, PhD

University of Manitoba
Winnipeg, Canada

Rivka Dresner-Pollak, MD

Hadassah Medical Organization - Hebrew University of Jerusalem
Jerusalem, Israel

Jason Gertz, PhD

University of Utah School of Medicine
Salt Lake City, Utah, USA

Celso E. Gomez-Sanchez, MD

University of Mississippi Medical Center
Madison, Mississippi, USA

Elise P. Gomez-Sanchez, DVM, PhD

University of Mississippi Medical Center
Jackson, Mississippi, USA

David J. Handelsman, MB BS, PhD, FRACP, FAHMS

ANZAC Research Institute, University of Sydney
Sydney, Australia

Sean M. Hartig, PhD

Baylor College of Medicine
Houston, Texas, USA

Tohru Hira, PhD

Hokkaido University
Sapporo, Japan

Fang Hu, Phd

Second Xiangya Hospital of Central South University
Changsha, China

Zeping Hu, PhD

Tsinghua University
Beijing, China

Oto-Obong Idah, BSc, MSc

University of Jos
Jos, Nigeria

Naureen Javeed, MSc, PhD

Mayo Clinic
Rochester, Minnesota, USA

Jamie W. Joseph, PhD

University of Waterloo
Kitchener, Ontario, Canada

Michael J. Joyner, MD

Mayo Clinic
Rochester, Minnesota, USA

Melkam A. Kebede, PhD

University of Sydney
Sydney, Australia

Rhonda D. Kineman, PhD

University of Illinois
Chicago, Illinois, USA

Monica M. Laronda, PhD

Ann & Rober H. Lurie Children's Hospital of Chicago, Northwestern University
Chicago, Illinois, USA

Michaël R. Laurent, MD, PhD

Imelda Hospital
Bonheiden, Belgium

Paul R. Le Tissier, PhD

University of Edinburgh
Edinburgh, United Kingdom

Jon E. Levine, PhD

University of Wisconsin-Madison
Madison, Wisconsin, USA

Rong Li, PhD

University of Missouri School of Medicine
Columbia, Missouri, USA

Ji Liu, MD, PhD

University of Science and Technology of China
Hefei, China

Francis Lynn, PhD

University of British Columbia
Vancouver, British Columbia, Canada

Pamela Mattar, PhD

University of California, Los Angeles
Los Angeles, California, USA

Alina P. Montalbano, PhD

UT Southwestern Medical Center
Dallas, Texas, USA

Lydie Naulé, PhD

Sorbonne Université
Paris, France

Erik R. Nelson, PhD

University of Illinois at Urbana-Champaign
Urbana, Illinois, USA

Craig S. Nunemaker, PhD

Ohio University
Athens, Ohio, USA

Julie H. Ostrander, PhD

University of Minnesota
Minneapolis, Minnesota, USA

Vasantha Padmanabhan, MS, PhD

University of Michigan
Ann Arbor, Michigan, USA

Jo K. Perry, PhD

University of Auckland
Auckland, New Zealand

Nadia Rachdaoui, PhD

NutrArgan, LLC
Branchburg, New Jersey, USA

Hershel Raff, PhD

Medical College of Wisconsin
Milwaukee, Wisconsin, USA

Jonathan V. Rocheleau, PhD

University of Toronto
Toronto, Ontario, Canada

Adam Rose, PhD

Monash University
Melbourne, Australia

Ingo Rustenbeck, MD, PhD

Technische Universität Braunschweig
Braunschweig, Germany

Shogo Sato, PhD

Texas A&M University
College Station, Texas, USA

Wei Shen, PhD

ShanghaiTech University
Shanghai, China

Scott A. Soleimanpour, MD

University of Michigan Medical School
Ann Arbor, Michigan, USA

Jennifer S. Stancill, PhD

Medical University of South Carolina
Charleston, South Carolina, USA

Raphael E. Szawka, PhD

Universidade Federal de Minas Gerais
Belo Horizonte, Brazil

Lindsey S. Treviño, PhD

City of Hope National Medical Center
Duarte, California, USA

Yoichi Ueta, MD, PhD

University of Occupational and Environmental Health, Japan
Kitakyushu, Japan

Desmaré van Rooyen, PhD